store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAPI1 (TAPI) 是一种 ADAM17/TACE 抑制剂,可抑制细胞因子受体的脱落。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,587 | 5日内发货 | ||
5 mg | ¥ 5,897 | 5日内发货 | ||
10 mg | ¥ 9,987 | 5日内发货 |
产品描述 | TAPI1 (TAPI) , an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors. |
体外活性 | TAPI-1 prevents unstimulated and PMA-induced release of the soluble forms of TNF-alpha, p60 TNFR, and IL-6R from the monocytic cell line, THP-1, and from human peripheral blood monocytes. TAPI also inhibits LPS-induced shedding of the p60 TNFR and TNF-alpha from monocytes. [1] TAPI-1 inhibits TACE-dependent constitutive release of co-transfected APP(695). [2] TAPI-1 attenuates Ang II-induced EGFR transactivation and cell proliferation in human HSC line LI90. [3] TAPI-1 with the EGFR inhibitor AG1478 exhibits deactivated AREG/EGFR/ERK signaling pathway and reduces pro-inflammatory cytokines release in pSS salivary gland-derived epithelial cells. [4] |
细胞实验 | Five thousand cells are seeded into each well of 96-well plates and their viability is assessed by CellTiter-Glo Luminescent Cell Viability assay. Upon serum deprivation for 24 h, the cells are treated with Ang II for 60 h with and without pretreatment with each inhibitor and antagonist. The assay substrates are then added to each well on the plate and the samples are evaluated using a luminometer. (Only for Reference) |
别名 | TAPI 1, TAPI, TAPI-1 |
分子量 | 499.612 |
分子式 | C26H37N5O5 |
CAS No. | 163847-77-6 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 92 mg/mL (184.1 mM)
H2O: 55 mg/mL (110.1 mM)
DMSO: 92 mg/mL (184.1 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / H2O / DMSO | 1 mM | 2.0016 mL | 10.0078 mL | 20.0155 mL | 50.0388 mL |
5 mM | 0.4003 mL | 2.0016 mL | 4.0031 mL | 10.0078 mL | |
10 mM | 0.2002 mL | 1.0008 mL | 2.0016 mL | 5.0039 mL | |
20 mM | 0.1001 mL | 0.5004 mL | 1.0008 mL | 2.5019 mL | |
50 mM | 0.04 mL | 0.2002 mL | 0.4003 mL | 1.0008 mL | |
100 mM | 0.02 mL | 0.1001 mL | 0.2002 mL | 0.5004 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TAPI1 163847-77-6 Proteases/Proteasome MMP cell surface proteins TAPI 1 Inhibitor Matrix metalloproteinases TAPI TAPI-1 Isomer TAPI-1 inhibit inhibitor